Drug shortage
Naltrexone Hydrochloride Tablet · Chartwell Molecular Holdings LLC
FDA drug shortage · Current · updated Mar 24, 2025
Key facts
| Generic name | Naltrexone Hydrochloride Tablet |
|---|---|
| Proprietary name | Naltrexone Hydrochloride |
| Company | Chartwell Molecular Holdings LLC |
| Presentation | Naltrexone Hydrochloride, Tablet, 50 mg (NDC 62135-242-60) |
| Dosage form | Tablet |
| Strength | 50 mg |
| Status | Current |
| Therapeutic category | Analgesia/Addiction |
| Package NDCs | 62135-242-60 |
| First posted | Feb 29, 2024 |
| Last updated | Mar 24, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: